CD&R, Merck GHI and McKesson Ventures Recapitalize M2GEN

CD&R Acquires Multi-Color Corporation and Fort Dearborn to Create Global Label Solutions Leader

November 1, 2021

Packaging

Clayton, Dubilier & Rice (CD&R) agreed to acquire Multi-Color Corporation (MCC) from Platinum Equity and Fort Dearborn Company from Advent International and combine the two businesses into a single global label solutions platform. The combined company will serve consumer packaged goods customers across Food & Beverage, Home & Personal Care, Wine & Spirits and other specialty end markets, creating roughly $3 billion in annual revenue and expanded global scale.

CD&R Acquires Majority Stake in Humana's Kindred at Home Hospice and Personal Care Divisions (Gentiva)

April 21, 2022

Healthcare Services

Clayton, Dubilier & Rice (CD&R) agreed to acquire a 60% interest in the Hospice and Personal Care divisions of Humana’s Kindred at Home, receiving approximately $2.8 billion in cash and valuing the divisions at about $3.4 billion. The carved‑out businesses were restructured into a standalone company rebranded as Gentiva, with Humana retaining a 40% minority stake and David Causby continuing as CEO; the deal closed in 2022 and remains subject to customary approvals noted at signing.

Clayton, Dubilier & Rice Partners with Vera Whole Health

July 1, 2021

Healthcare Services

Clayton, Dubilier & Rice (CD&R) has entered into an investment partnership with Vera Whole Health to support Vera's expansion of its value-based, primary care-focused model. Terms were not disclosed; existing minority investors Transformation Capital and Archimedes Health Investors will remain as minority stakeholders while CD&R will support growth and board leadership changes.

Clayton, Dubilier & Rice Acquires Huntsworth plc

May 1, 2020

Healthcare Services

Clayton, Dubilier & Rice (CD&R) agreed a recommended cash offer and completed the take-private acquisition of Huntsworth plc for approximately £575 million. CD&R said it will invest in Huntsworth’s healthcare-focused commercialization services—including medical affairs, market access and marketing—to support organic and acquisition-led growth under private ownership.

Clayton, Dubilier & Rice Acquires Majority Stake in Sirius Computer Solutions

July 1, 2019

IT Services

Clayton, Dubilier & Rice (CD&R) acquired a majority equity interest in Sirius Computer Solutions from funds affiliated with Kelso & Company. The partnership positions CD&R to support Sirius’ continued growth and expand its managed services, cloud, security and solutions offerings while Joe Mertens remains CEO.

Research Corporation Technologies Acquires Translational Drug Development (TD2)

June 4, 2020

Healthcare Services

Research Corporation Technologies, Inc. (RCT) has acquired Translational Drug Development (TD2) and provided growth capital to expand TD2's precision oncology drug development services. The transaction will scale TD2's translational preclinical, regulatory and clinical trial capabilities to better serve biotechnology and pharmaceutical clients.